# Macrophage Inflammatory Proteins (MIPs) Contribute to Malignant Potential of Colorectal Polyps and Modulate Likelihood of Cancerization Associated with Standard Risk Factors

**Authors:** Jarosław Wierzbicki, Iwona Bednarz-Misa, Łukasz Lewandowski, Artur Lipiński, Anna Kłopot, Katarzyna Neubauer, Małgorzata Krzystek-Korpacka

PMC · DOI: 10.3390/ijms25031383 · International Journal of Molecular Sciences · 2024-01-23

## TL;DR

This study explores how macrophage inflammatory proteins (MIPs) influence the likelihood of colorectal polyps becoming cancerous.

## Contribution

The study identifies how specific MIPs modulate cancer risk in polyps and their adjacent mucosa.

## Key findings

- CCL3, CCL4, and CCL19 expression decreases with increasing malignancy potential of polyps.
- CXCL2 expression increases in normal mucosa as polyps progress toward malignancy.
- MIPs modulate cancerization likelihood associated with traditional risk factors.

## Abstract

Better understanding of molecular changes leading to neoplastic transformation is prerequisite to optimize risk assessment and chemopreventive and surveillance strategies. Data on macrophage inflammatory proteins (MIPs) in colorectal carcinogenesis are scanty and their clinical relevance remains unknown. Therefore, transcript and protein expression of CCL3, CCL4, CXCL2, and CCL19 were determined in 173 and 62 patients, respectively, using RT-qPCR and immunohistochemistry with reference to polyps’ characteristics. The likelihood of malignancy was modeled using probit regression. With the increasing malignancy potential of hyperplastic–tubular–tubulo-villous–villous polyps, the expression of CCL3, CCL4, and CCL19 in lesions decreased. CCL19 expression decreased also in normal mucosa while that of CXCL2 increased. Likewise, lesion CCL3 and lesion and normal mucosa CCL19 decreased and normal CXCL2 increased along the hyperplasia–low–high dysplasia grade. The bigger the lesion, the lower CCL3 and higher CXCL2 in normal mucosa. Singular polyps had higher CCL3, CCL4, and CCL19 levels in normal mucosa. CCL3, CCL4 and CXCL2 modulated the likelihood of malignancy associated with traditional risk factors. There was no correlation between the protein and mRNA expression of CCL3 and CCL19. In summary, the polyp-adjacent mucosa contributes to gaining potential for malignancy by polyps. MIPs may help in specifying cancerization probability estimated based on standard risk factors.

## Linked entities

- **Genes:** CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348], CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351], CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920], CCL19 (C-C motif chemokine ligand 19) [NCBI Gene 6363]
- **Diseases:** colorectal cancer (MONDO:0005575)

## Full-text entities

- **Genes:** CCL19 (C-C motif chemokine ligand 19) [NCBI Gene 6363] {aka CKb11, ELC, MIP-3b, MIP3B, SCYA19}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920] {aka CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}
- **Diseases:** colorectal carcinogenesis (MESH:D063646), polyp (MESH:D011127), hyperplasia (MESH:D006965), Colorectal Polyps (MESH:D003111), dysplasia (MESH:D015792), Cancerization (MESH:D009369), -villous-villous polyps (MESH:D018253)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10855842/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10855842/full.md

## References

83 references — full list in the complete paper: https://tomesphere.com/paper/PMC10855842/full.md

---
Source: https://tomesphere.com/paper/PMC10855842